Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

884
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
884
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Long-term Depression01:03

Long-term Depression

2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of a Telehealth-Based Rapid Access Program for the Evaluation of Men Referred for Elevated Prostate-Specific Antigen.

Urology practice·2026
Same author

Using Case-Based Teaching: Does Our Dysregulated Hospitalized Patient Have Borderline Personality or Autism Spectrum Disorder?

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2024
Same author

Advanced Practice Providers in U.S. Urology: A National Survey of Demographics and Clinical Roles.

Urology practice·2023
Same author

Publishing on a Shoestring: Understanding Barriers, Challenges, and Unique Opportunities to Academic Productivity in Psychiatry.

Current psychiatry reports·2023
Same author

Standardized Office Cystoscopy Training for Advanced Practice Providers in Urology.

Urology practice·2023
Same author

Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment.

International journal of particle therapy·2020

Related Experiment Video

Updated: Apr 29, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.8K

Screening for depression in the primary care population.

D Edward Deneke1, Heather Schultz1, Thomas E Fluent1

  • 1Department of Psychiatry, University of Michigan Health System, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, USA.

Primary Care
|May 17, 2014
PubMed
Summary

Primary care depression treatment faces challenges. Implementing evidence-based models requires better funding and addressing clinical culture barriers, with the Affordable Care Act offering potential solutions.

Keywords:
DepressionPrimary careScreeningSuicide

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K

Related Experiment Videos

Last Updated: Apr 29, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.8K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K

Area of Science:

  • Primary care
  • Mental health services
  • Healthcare policy

Background:

  • Depression diagnosis and treatment in primary care present significant challenges.
  • Effective depression screening necessitates robust systems for clinician treatment and patient adherence.
  • Existing evidence-based depression care models face slow adoption due to funding and cultural issues.

Purpose of the Study:

  • To examine the challenges in primary care depression diagnosis and treatment.
  • To explore the facilitators and barriers to adopting new evidence-based depression care models.
  • To assess the potential impact of the Affordable Care Act on collaborative care models for depression.

Main Methods:

  • Review of current literature on depression care in primary settings.
  • Analysis of barriers to the implementation of evidence-based models.
  • Examination of healthcare policy changes, including the Affordable Care Act, and their implications.

Main Results:

  • Screening for depression is effective only when integrated with reliable treatment and adherence systems.
  • Slow uptake of new models is linked to inadequate funding and clinical culture conflicts.
  • The Affordable Care Act may offer opportunities for improved funding structures to support collaborative care.

Conclusions:

  • Addressing depression in primary care requires overcoming systemic barriers.
  • Collaborative care models show promise but need supportive funding and cultural integration.
  • Suicide screening in primary care remains a contentious issue requiring further consideration.